Muscle strength in breast cancer patients receiving different treatment regimes.

ABSTRACT:

Background

Muscle dysfunction and sarcopenia have been associated with poor performance status, an increased mortality risk, and greater side effects in oncologic patients. However, little is known about how performance is affected by cancer therapy. We investigated muscle strength in breast cancer patients in different adjuvant treatment settings and also compared it with data from healthy individuals.

Methods

Breast cancer patients (N = 255) from two randomized controlled exercise trials, staged 0-III and aged 54.4 ± 9.4 years, were categorized into four groups according to their treatment status. In a cross-sectional design, muscle function was assessed bilaterally by isokinetic dynamometry (0°, 60°, 180°/s) as maximal voluntary isometric contraction (MVIC) and maximal is

SUBMITTER: Klassen O 

PROVIDER: S-EPMC5377413 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature